← All Sponsors

SPONSOR

Jiangxi Provincial Cancer Hospital

Total Trials

1

Recruiting

1

Phases

Phase 2

Conditions studied: Esophageal Squamous Cell Carcinoma Esophageal Neoplasms Esophageal Diseases Gastrointestinal Neoplasms Gastrointestinal Diseases Digestive System Neoplasms Digestive System Diseases Neoplasms by Site Neoplasms by Histologic Type Neoplasms, Squamous Cell

NCT05252078 Phase 2

Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients

Esophageal Squamous Cell Carcinoma